GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Inventories, Raw Materials & Components

Kineta (STU:J75) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Inventories, Raw Materials & Components?

Kineta's inventories, raw materials & components for the quarter that ended in Jun. 2024 was €0.00 Mil.


Kineta Inventories, Raw Materials & Components Historical Data

The historical data trend for Kineta's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Inventories, Raw Materials & Components Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
- - - -

Kineta Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kineta Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Kineta Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Inventories, Raw Materials & Components
Traded in Other Exchanges
Address
7683 SE 27th Street, Suite 481, Mercer Island, WA, USA, 98040
Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.

Kineta Headlines

No Headlines